Cargando…
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577877/ https://www.ncbi.nlm.nih.gov/pubmed/34748627 http://dx.doi.org/10.1182/blood.2021014124 |
_version_ | 1784596152599969792 |
---|---|
author | Pagano, Livio Salmanton-García, Jon Marchesi, Francesco López-García, Alberto Lamure, Sylvain Itri, Federico Gomes-Silva, Maria Dragonetti, Giulia Falces-Romero, Iker van Doesum, Jaap Sili, Uluhan Labrador, Jorge Calbacho, Maria Bilgin, Yavuz M. Weinbergerová, Barbora Serrano, Laura Ribera-Santa Susana, José-María Malak, Sandra Loureiro-Amigo, José Glenthøj, Andreas Córdoba-Mascuñano, Raúl Nunes-Rodrigues, Raquel González-López, Tomás-José Karlsson, Linda Katharina Jiménez-Lorenzo, María-Josefa Hernández-Rivas, José-Ángel Jaksic, Ozren Ráčil, Zdeněk Busca, Alessandro Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. |
author_facet | Pagano, Livio Salmanton-García, Jon Marchesi, Francesco López-García, Alberto Lamure, Sylvain Itri, Federico Gomes-Silva, Maria Dragonetti, Giulia Falces-Romero, Iker van Doesum, Jaap Sili, Uluhan Labrador, Jorge Calbacho, Maria Bilgin, Yavuz M. Weinbergerová, Barbora Serrano, Laura Ribera-Santa Susana, José-María Malak, Sandra Loureiro-Amigo, José Glenthøj, Andreas Córdoba-Mascuñano, Raúl Nunes-Rodrigues, Raquel González-López, Tomás-José Karlsson, Linda Katharina Jiménez-Lorenzo, María-Josefa Hernández-Rivas, José-Ángel Jaksic, Ozren Ráčil, Zdeněk Busca, Alessandro Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. |
author_sort | Pagano, Livio |
collection | PubMed |
description | In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor serologic responses to vaccination to higher risk for breakthrough infection, hospitalization, and death in patients with blood cancer, especially those on active antineoplastic therapy. In an accompanying Letter to Blood, Pagano et al provide supportive data using a multination survey approach to capture outcomes for COVID-19 in vaccinated patients with hematologic neoplasms. They also emphasize the higher risk among patients with lymphoid malignancies. Together, these findings argue for both continued deployment of booster programs and ongoing public health guidance for this vulnerable group. |
format | Online Article Text |
id | pubmed-8577877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85778772021-11-10 COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA Pagano, Livio Salmanton-García, Jon Marchesi, Francesco López-García, Alberto Lamure, Sylvain Itri, Federico Gomes-Silva, Maria Dragonetti, Giulia Falces-Romero, Iker van Doesum, Jaap Sili, Uluhan Labrador, Jorge Calbacho, Maria Bilgin, Yavuz M. Weinbergerová, Barbora Serrano, Laura Ribera-Santa Susana, José-María Malak, Sandra Loureiro-Amigo, José Glenthøj, Andreas Córdoba-Mascuñano, Raúl Nunes-Rodrigues, Raquel González-López, Tomás-José Karlsson, Linda Katharina Jiménez-Lorenzo, María-Josefa Hernández-Rivas, José-Ángel Jaksic, Ozren Ráčil, Zdeněk Busca, Alessandro Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Blood Letters to Blood In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor serologic responses to vaccination to higher risk for breakthrough infection, hospitalization, and death in patients with blood cancer, especially those on active antineoplastic therapy. In an accompanying Letter to Blood, Pagano et al provide supportive data using a multination survey approach to capture outcomes for COVID-19 in vaccinated patients with hematologic neoplasms. They also emphasize the higher risk among patients with lymphoid malignancies. Together, these findings argue for both continued deployment of booster programs and ongoing public health guidance for this vulnerable group. American Society of Hematology 2022-03-10 /pmc/articles/PMC8577877/ /pubmed/34748627 http://dx.doi.org/10.1182/blood.2021014124 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Letters to Blood Pagano, Livio Salmanton-García, Jon Marchesi, Francesco López-García, Alberto Lamure, Sylvain Itri, Federico Gomes-Silva, Maria Dragonetti, Giulia Falces-Romero, Iker van Doesum, Jaap Sili, Uluhan Labrador, Jorge Calbacho, Maria Bilgin, Yavuz M. Weinbergerová, Barbora Serrano, Laura Ribera-Santa Susana, José-María Malak, Sandra Loureiro-Amigo, José Glenthøj, Andreas Córdoba-Mascuñano, Raúl Nunes-Rodrigues, Raquel González-López, Tomás-José Karlsson, Linda Katharina Jiménez-Lorenzo, María-Josefa Hernández-Rivas, José-Ángel Jaksic, Ozren Ráčil, Zdeněk Busca, Alessandro Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title | COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title_full | COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title_fullStr | COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title_full_unstemmed | COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title_short | COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA |
title_sort | covid-19 in vaccinated adult patients with hematological malignancies: preliminary results from epicovideha |
topic | Letters to Blood |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577877/ https://www.ncbi.nlm.nih.gov/pubmed/34748627 http://dx.doi.org/10.1182/blood.2021014124 |
work_keys_str_mv | AT paganolivio covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT salmantongarciajon covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT marchesifrancesco covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT lopezgarciaalberto covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT lamuresylvain covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT itrifederico covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT gomessilvamaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT dragonettigiulia covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT falcesromeroiker covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT vandoesumjaap covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT siliuluhan covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT labradorjorge covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT calbachomaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT bilginyavuzm covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT weinbergerovabarbora covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT serranolaura covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT riberasantasusanajosemaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT malaksandra covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT loureiroamigojose covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT glenthøjandreas covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT cordobamascunanoraul covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT nunesrodriguesraquel covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT gonzalezlopeztomasjose covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT karlssonlindakatharina covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT jimenezlorenzomariajosefa covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT hernandezrivasjoseangel covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT jaksicozren covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT racilzdenek covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT buscaalessandro covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT corradinipaolo covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT hoeniglmartin covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT klimkonikolai covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT koehlerphilipp covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT pagliucaantonio covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT passamontifrancesco covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha AT cornelyolivera covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha |